7-hydroxystaurosporine (UCN-01)

DRUG2 trials

Sponsors

National Cancer Institute (NCI), M.D. Anderson Cancer Center

Conditions

Breast CancerLeukemiaLymphomaMyelodysplastic SyndromesNeoplasmProstatic Neoplasm

Phase 1

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

CompletedNCT00001444

National Cancer Institute (NCI)Breast Cancer, Lymphoma, Neoplasm +1

Start: 1995-08-31End: 2002-05-31Target: 51Updated: 2008-03-04

Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

CompletedNCT00004263

M.D. Anderson Cancer CenterLeukemia, Myelodysplastic Syndromes

Start: 1999-12-31End: 2007-01-31Updated: 2012-07-30